Contact UsQuotation
Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty
Proceed to checkoutContinue shopping
TOPBioactivityChemical infoStorage&SolubilityCalculator

Tertiapin LQ TFA

Copy Product Info
😃Good
Catalog No. T83749
Alias TPNLQ

Tertiapin LQ, a peptide derivative of honeybee venom peptide tertiapin, acts as an inhibitor of inwardly rectifying potassium (Kir) channels. Specifically, it targets and inhibits heteromultimeric potassium channels, including those formed by GIRK1 (also known as Kir3.1) and GIRK4 (Kir3.4), as well as inward-rectifier potassium channel 1 (Kir1.1). Its efficaciousness extends to in vivo applications, where it has been observed to suppress the Purkinje cell pause response to conditional stimuli in ferrets.

Tertiapin LQ TFA
Other Forms of Tertiapin LQ TFA:
Tertiapin LQTP2113
Backorder
View details

Tertiapin LQ TFA

Copy Product Info
😃Good
Catalog No. T83749Alias TPNLQ
Tertiapin LQ, a peptide derivative of honeybee venom peptide tertiapin, acts as an inhibitor of inwardly rectifying potassium (Kir) channels. Specifically, it targets and inhibits heteromultimeric potassium channels, including those formed by GIRK1 (also known as Kir3.1) and GIRK4 (Kir3.4), as well as inward-rectifier potassium channel 1 (Kir1.1). Its efficaciousness extends to in vivo applications, where it has been observed to suppress the Purkinje cell pause response to conditional stimuli in ferrets.
Pack SizePriceUSA WarehouseGlobal WarehouseQuantity
1 mg$342InquiryInquiry
5 mg$1,530InquiryInquiry
10 mg$1,980InquiryInquiry
Add to Cart
Add to Quotation
In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Questions
TargetMol
View More

Resource Download

Product Introduction

Bioactivity
Description
Tertiapin LQ, a peptide derivative of honeybee venom peptide tertiapin, acts as an inhibitor of inwardly rectifying potassium (Kir) channels. Specifically, it targets and inhibits heteromultimeric potassium channels, including those formed by GIRK1 (also known as Kir3.1) and GIRK4 (Kir3.4), as well as inward-rectifier potassium channel 1 (Kir1.1). Its efficaciousness extends to in vivo applications, where it has been observed to suppress the Purkinje cell pause response to conditional stimuli in ferrets.
SynonymsTPNLQ
Chemical Properties
Molecular Weight2428.03
FormulaC106H179N33O24S4.XCF3COOH
Smiles[H]N[C@H](C(N[C@@H](CC(C)C)C(N[C@H](C(N[C@@H](CC(N)=O)C(N[C@H](C(N[C@@H](CC(N)=O)C(N[C@@H](CCCNC(N)=N)C(N[C@]([C@H](CC)C)([H])C(N[C@]([C@H](CC)C)([H])C(N[C@]([C@H](CC)C)([H])C(N1CCC[C@H]1C(N[C@@H](CC(C)C)C(N[C@@H](CCC(N)=O)C2=O)=O)=O)=O)=O)=O)=O)=O)=O)CSSC[C@H](N3)C(NCC(N[C@@H](CCCCN)C(N[C@@H](CCCCN)C(N)=O)=O)=O)=O)=O)=O)CSSC[C@H](N2)C(N[C@H](C(N[C@@H](CCCCN)C(N[C@@H](CCCCN)C3=O)=O)=O)CC4=CNC5=C4C=CC=C5)=O)=O)=O)C.OC(C(F)(F)F)=O
SequenceH-Ala-Leu-Cys(1)-Asn-Cys(2)-Asn-Arg-Ile-Ile-Ile-Pro-Leu-Gln-Cys(1)-Trp-Lys-Lys-Cys(2)-Gly-Lys-Lys-NH2
Sequence ShortALCNCNRIIIPLQCWKKCGKK
Storage & Solubility Information
Storagekeep away from moisture | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
Solubility Information
H2O: Soluble

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:
TargetMol | Animal experiments For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, TargetMol | Animal experiments and a total of 10 animals are to be administered, using a formulation of TargetMol | reagent 10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH2O , the resulting working solution concentration would be 2 mg/mL.
Stock Solution Preparation:

Dissolve 2 mg of the compound in 100 μL DMSOTargetMol | reagent to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.

Preparation of the In Vivo Formulation:

1) Add 100 μL of the DMSOTargetMol | reagent stock solution to 400 μL PEG300TargetMol | reagent and mix thoroughly until the solution becomes clear.

2) Add 50 μL Tween 80 and mix well until fully clarified.

3) Add 450 μL Saline,PBS or ddH2OTargetMol | reagent and mix thoroughly until a homogeneous solution is obtained.

This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.
All co-solvents required for this protocol, includingDMSO, PEG300/PEG400, Tween 80, SBE-β-CD, and Corn oil, are available for purchase on the TargetMol website.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
% Tween 80
% Saline/PBS/ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc
Related Tags: buy Tertiapin LQ TFA | purchase Tertiapin LQ TFA | Tertiapin LQ TFA cost | order Tertiapin LQ TFA | Tertiapin LQ TFA chemical structure | Tertiapin LQ TFA formula | Tertiapin LQ TFA molecular weight
TargetMol | Logo

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.